NCT02937948已完成不适用
Phase II Study of Adaptative Radiotherapy for Locally Advanced Cervical Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 85
- 试验地点
- 22
- 主要终点
- Number of patient having an Acute genito-urinary (GU) and Gastro-intestinal (GI) toxicities assessed by CTCAE V4.03
研究概览
简要总结
This study evaluates the effect of adaptative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of locally advanced cervical cancer on acute genito-urinary (GU), and gastrointestinal (GI) toxicities. Every patients will be treated according to the adaptative IMRT strategy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Cervix carcinoma proved by histology
- •According International Federation of Gynecology and Obstetrics (FIGO) classification, stages IB2, IIA, IIB, IIIA and IIIB without lumbo-aortic lymph node damage (surgical or radiologic)
- •Patient treated with radio-chemotherapy then curietherapy with curative aim, validated in multidisciplinary meeting
- •Renal, hepatic and cardiovascular functions that allow administration of the associated systemic treatment
- •Older than 18 years
- •Good general status, World Health Organization less or equal to 1
- •Signed informed consent
排除标准
- •History of cancer that is not controlled and / or treated for less than 5 years (excepted for cutaneous baso-cellular cancer)
- •History of pelvic irradiation
- •Simultaneous participation to another research that could interfere with the study results
- •Pregnant or breastfeeding patient
- •Patient under tutor or guardian
- •Patient not able to respect medical follow-up for geographical, social or psychological reasons
- •Not affiliated to a system of French social security
结局指标
主要结局
Number of patient having an Acute genito-urinary (GU) and Gastro-intestinal (GI) toxicities assessed by CTCAE V4.03
时间窗: 3 months after end of radio-chemotherapy treatment
次要结局
- Number of patient having a Grade ≥ 2 Hematologic and other toxicities assessed by CTCAE V4.03(3 months after end of radio-chemotherapy treatment)
研究者
研究点 (22)
Loading locations...
相似试验
Enrolling By Invitation
2 期
IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsElderlyChemotherapyNCT06688175The First Affiliated Hospital of Xiamen University32
已完成
2 期
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By SurgeryCervical CancerEndometrial CancerNCT00331760Radiation Therapy Oncology Group106
进行中（未招募）
不适用
UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)Glioblastoma Multiforme, AdultNCT05720078Sunnybrook Health Sciences Centre70
撤回
2 期
Intensity-Modulated Radiotherapy for Recurrent Head and Neck CancerCarcinoma of the Head and NeckNCT00257335Nilam Ramsinghani
招募中
不适用
Pelvis Adaptive Radiotherapy (ART)Pelvis NeoplasmsNCT06650033Royal North Shore Hospital280